INNOVATIVE PANEL OF BIOMARKERS FOR PERSONALIZED MONITORING OF THE TUMOR PROCESS

PURPOSE:

For personalized monitoring of the tumor process, correction of the treatment regimen and improving the quality of life of cancer patients.

DESCRIPTION:

The method is based on the determination of a new class of highly sensitive, tissue-specific epigenetic tumor markers – microRNAs and the analysis of their correlation dependencies with the characteristics of the molecular profile of tumors.

ADVANTAGES:

MicroRNAs have a significant advantage over other biomarkers due to their stability, selectivity, and specificity for a particular type of tumor. Analysis of the level of one miRNA provides comprehensive information about the tumor (risk of relapse, degree of malignancy, sensitivity to chemo-, radio-hormone therapy, etc.). The use of the proposed panel of biomarkers is highly informative, sensitive and time-consuming.

RECOMMENDED FIELD OF APPLICATION:

Medicine.

RESULTS OF THE RESEARCH:

Provides consistent results.

STAGE OF THE DEVELOPMENT READINESS:

Tested in trial operation.

TRANSFER OPPORTUNITY:

Joint production, sale, operation.

NOVELTY:

1 patent of Ukraine.

 

IF YOU ARE INTERESTED IN THIS DEVELOPMENT, PLEASE,

WRITE TO US

Leave a Reply

Your email address will not be published.